Key facts
| Recalling firm | Medical Action Industries, Inc. 306 |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing Medline Namic Angiographic Star Off Handle Manifolds |
| Classification | Class I |
| Recall number | Z-2792-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Cardiovascular procedure kits contain manifolds, the subject of another recall, that may have particulate within the fluid path, which has the potential to be introduced into blood circulation and become lodged within blood vessels. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing Medline Namic Angiographic Star Off Handle Manifolds should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medical Action Industries, Inc. 306. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medical Action Industries, Inc. 306 should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medical Action Industries, Inc. 306 directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Medical Action Industries, Inc. 306’s FDA history
Argus HQ has recorded 3 total FDA actions tied to Medical Action Industries, Inc. 306: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing recalled?
- Yes. FDA lists a Class I recall by Medical Action Industries, Inc. 306 for Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing Medline Namic Angiographic Star Off Handle Manifolds, reported 20260805, with status "Ongoing." FDA recall number: Z-2792-2026.
- What is the recall class for Medical Action Industries, Inc. 306's recall?
- FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.
- Why was Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing recalled?
- FDA's recall record states the reason as: Cardiovascular procedure kits contain manifolds, the subject of another recall, that may have particulate within the fluid path, which has the potential to be introduced into blood circulation and become lodged within blood vessels.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medical Action Industries, Inc. 306Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class I Recall: Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing… by Medical Action Industries, Inc. 306. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/medical-action-industries-306-z-2792-2026-2026-08-05
"FDA Class I Recall: Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing… by Medical Action Industries, Inc. 306." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/medical-action-industries-306-z-2792-2026-2026-08-05.
Argus HQ Research. "FDA Class I Recall: Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing… by Medical Action Industries, Inc. 306." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/recall/medical-action-industries-306-z-2792-2026-2026-08-05.
@misc{argushq_argushq_ai_recall_medical_action_industries_306_z_2792_2026_2026_08_05_2026,
title = {FDA Class I Recall: Pack Angiography NCMC 3/Cs BANNER, REF: NCAG62I, containing… by Medical Action Industries, Inc. 306},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/medical-action-industries-306-z-2792-2026-2026-08-05},
note = {Accessed: August 27, 2026}
}Source: FDA.gov — Recalls ↗

